泰山医学院学报
泰山醫學院學報
태산의학원학보
JOURNAL OF TAISHAN MEDICAL COLLEGE
2015年
6期
631-632
,共2页
支原体%衣原体%非淋菌性尿道炎%克拉霉素%托氟沙星
支原體%衣原體%非淋菌性尿道炎%剋拉黴素%託氟沙星
지원체%의원체%비림균성뇨도염%극랍매소%탁불사성
mycoplasma%chlamydia%non gonococcal urethritis%clarithromycin%tosufloxacin
目的：探讨克拉霉素与托氟沙星联用治疗支原体衣原体非淋菌性尿道炎的临床效果。方法将我院2011年8月~2013年1月收治的120支原体衣原体非淋菌性尿道炎患者随机分为克拉霉素组、托氟沙星组合联合组各40例。克拉霉素组给予口服克拉霉素胶囊0.25 g，托氟沙星组给予口服托氟沙星胶囊0.3 g，联合组口服克拉霉素0.25 g、托氟沙星0.3 g，疗程14天，观察和对比各组的临床疗效。结果克拉霉素治疗非淋菌性尿道炎的疗效及复发率与托氟沙星比较差异无显著性（P >0.05），联合用药组治疗非淋菌性尿道炎效果显著，复发率低，与克托霉素组和托氟沙星组比较差异有显著性（P <0.05）。结论克拉霉素与托氟沙星联合治疗支原体衣原体非淋菌性尿道炎疗效显著、安全、服用方便，不良反应低，复发少。具有高效、安全、服用方便等特点，是一种值得推广的临床技术。
目的：探討剋拉黴素與託氟沙星聯用治療支原體衣原體非淋菌性尿道炎的臨床效果。方法將我院2011年8月~2013年1月收治的120支原體衣原體非淋菌性尿道炎患者隨機分為剋拉黴素組、託氟沙星組閤聯閤組各40例。剋拉黴素組給予口服剋拉黴素膠囊0.25 g，託氟沙星組給予口服託氟沙星膠囊0.3 g，聯閤組口服剋拉黴素0.25 g、託氟沙星0.3 g，療程14天，觀察和對比各組的臨床療效。結果剋拉黴素治療非淋菌性尿道炎的療效及複髮率與託氟沙星比較差異無顯著性（P >0.05），聯閤用藥組治療非淋菌性尿道炎效果顯著，複髮率低，與剋託黴素組和託氟沙星組比較差異有顯著性（P <0.05）。結論剋拉黴素與託氟沙星聯閤治療支原體衣原體非淋菌性尿道炎療效顯著、安全、服用方便，不良反應低，複髮少。具有高效、安全、服用方便等特點，是一種值得推廣的臨床技術。
목적：탐토극랍매소여탁불사성련용치료지원체의원체비림균성뇨도염적림상효과。방법장아원2011년8월~2013년1월수치적120지원체의원체비림균성뇨도염환자수궤분위극랍매소조、탁불사성조합연합조각40례。극랍매소조급여구복극랍매소효낭0.25 g，탁불사성조급여구복탁불사성효낭0.3 g，연합조구복극랍매소0.25 g、탁불사성0.3 g，료정14천，관찰화대비각조적림상료효。결과극랍매소치료비림균성뇨도염적료효급복발솔여탁불사성비교차이무현저성（P >0.05），연합용약조치료비림균성뇨도염효과현저，복발솔저，여극탁매소조화탁불사성조비교차이유현저성（P <0.05）。결론극랍매소여탁불사성연합치료지원체의원체비림균성뇨도염료효현저、안전、복용방편，불량반응저，복발소。구유고효、안전、복용방편등특점，시일충치득추엄적림상기술。
Objective:Study of clarithromycin with tosufloxacin in the treatment of Mycoplasma non - gonococcal urethri-tis clinical effect. Method:Will my courtyard in 2011 August to 2013 January were 120 Mycoplasma non - gonococcal ure-thritis patients were randomly divided into groups,clarithromycin tosufloxacin combination of joint group with 40 cases in each group. Clarithromycin group were given oral clarithromycin capsules 0. 25 g,tosufloxacin group were given oral tosuflox-acin capsule combined with group 0. 3 g,0. 25 g,oral clarithromycin tosufloxacin 0. 3 g,course of treatment is 14 days,ob-serve and compare the clinical efficacy of each group. Results:Clarithromycin in the treatment of nongonococcal urethritis in therapeutic effects and recurrence rate and tosufloxacin had no significant differences( P > 0. 05 ),combination group treat-ment of nongonococcal urethritis effect,low recurrence rate,and G daptomycin group and tosufloxacin group had significant difference(P < 0. 05 ). Conclusion:Clarithromycin and tosufloxacin in combined treatment of nongonococcal urethritis My-coplasma pneumoniae curative effect,safety,convenient use,adverse reactions to low,less recurrence. With high efficien-cy,safety,convenient use and other characteristics,it is worthy of popularization in clinical techniques.
